With decades of committed service to the rapid test, Prometheus is committed to a true partnership with customers by providing easy, fast and accurate diagnostics products. Focusing on technology, innovation and quality control, our manufacturing covers a board range of areas: Drug Test Series; Women's Health Series, Cardiac markers Series; Infectious Disease Series and Tumor Markers Series. The DOA Cup Reader, scanning data from the urine cup, can lead the drug testing market, and the Up-Converting Fluorescence Quantitative Meter——spot measurement also has a considerable advantage in the market. Guided by our precise technology, we are continuously exchanging knowledge with our customers, partners, and clinicians to address the critical issues of improving care and lowering cost.
Prometheus' plant was granted ISO 9001:2008 & ISO 13485:2003 certification. In November 2012, Prometheus' production facility was inspected by US FDA and no 483 form was issued. High standards and compliance, to which Prometheus faithfully adheres, allow our customers to have the utmost confidence in the validity of their project.
The plant of Prometheus Bio Inc. was granted ISO 9001:2008 & ISO13485:2003 certification.
In 2012 and 2016, the production of Prometheus Bio Inc. facility was inspected by US FDA and no 483 form was issued.
The plant quality management system is subject to Chinese IVDs detailed implementation standards and inspected by CFDA in September 2008.
